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CHAPTER ONE
OVERVIEW AND HYPOTHESIS
Approximately 1 in 6 adolescents report regular binge alcohol consumption, based
on the National Institute of Alcohol Abuse and Alcoholism. Binge alcohol consumption is
a pattern of drinking that elevates blood alcohol content to 0.08 g/dL within 2 hours.
Adolescent binge alcohol exposure hampers normal brain development [1]. However, the
effects of adolescent binge alcohol consumption on the heart are almost entirely
unknown. Many studies have shown that alcohol consumption leads to complications
such as cardiovascular dysfunction, inhibition of myocardial fatty acid metabolism, and
ventricular hypertrophy and dilation, which can all lead to alcoholic cardiomyopathy in
adults [2-4]. The body grows rapidly during adolescence, and in order to meet the
increased oxygen demand and functional working tasks, the heart grows concurrently to
increase cardiac output [5, 6]. Yet, little is known about how binge alcohol exposure
impacts the growing heart.
Heart function and growth are supported by fatty acid metabolism, the preferred
energy utilization of the heart [7]. However, alcohol interrupts heart fatty acid metabolism,
and some key fatty acid metabolic genes have been shown to be down-regulated in
hypertrophied hearts [3][8], which suggests that adolescent myocardial fatty acid
metabolism may also be altered by binge alcohol exposure. In addition, alcohol
consumption induces cardiac remodeling [9], and it is well studied that β-adrenergic
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signaling regulates normal heart function [10] as well as remodeling during heart failure
in adults [11, 12]. One possibility is that alcohol exposure alters the heart structure by
directly stimulating β-adrenergic activation. We hypothesize that binge alcohol exposure
negatively impacts cardiac growth, activates β-adrenergic signaling, and decreases fatty
acid metabolic gene expression in the heart during adolescence.
We will address this hypothesis in the following two aims:
Aim 1: Assess cardiac structural and functional changes from binge alcohol
exposure during adolescence. One critical question is whether binge alcohol consumption
interrupts heart development in adolescence. It is my working hypothesis that upon binge
alcohol exposure, adolescent rats will have impaired cardiac function and increased
cardiomyocyte hypertrophy. We will adopt an established outbred adolescent male rat
model to analyze how binge alcohol exposure affects the heart structure and function
from postnatal day (PND) 36 to 44 (12-17 years in human). We will perform
echocardiography (M-mode and Doppler) at both baseline and post treatment to assess
cardiac structure and function. Immediately after sacrifice, blood alcohol content will be
measured to ensure the binge level of alcohol exposure. Plasma corticosterone level will
also be measured to control for the effect of alcohol stress on heart remodeling.
Histological staining will be used to determine individual cardiomyocyte hypertrophy.
Aim 2: Determine the changes on β-adrenergic signaling and fatty acid metabolic
genes in the heart after adolescent binge alcohol exposure. Changes to β-adrenergic
signaling and metabolic substrate utilization are common indications of stress responses
in the heart. It is my working hypothesis that binge alcohol exposure increases βadrenergic signaling as a short-term compensatory mechanism and decreases the fatty
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acid metabolism gene expressions in the heart. We will identify whether binge alcohol
exposure activates β-adrenergic signaling by PKA activity assay and western blot of
downstream protein phosphorylation. We will use LV tissue for RNAseq and RT-qPCR to
test the expression of overall gene expression changes in those rats, including several
key metabolic genes that regulate the fatty acid metabolism pathway. The plasma lipid
profile, as well as LV tissue triglyceride content, will be tested to determine possible
alteration on fatty acid metabolism to the body and specifically the heart by binge alcohol
exposure.
Adolescent binge alcohol consumption has become a growing problem worldwide.
This project allows us to improve our knowledge on how binge alcohol consumption
affects cardiac structure and function in the growing heart.

CHAPTER TWO
LITERATURE REVIEW
Binge Alcohol Consumption among Adolescents
Alcohol is the most commonly used and abused drug among youth in the United
States, based on statistics from the Centers For Disease Control and Prevention. The
2015 National Survey on Drug Use and Health (NSDUH) showed 33.1% of the survey
population have had at least 1 alcoholic drink by 15 years of age [13]. Adolescents aged
12 to 20 years drink 11% of all alcohol consumed nationwide, and more than 90% of
alcohol is consumed in a heavy episodic (binge) pattern [14]. Binge alcohol consumption
is a pattern of drinking that elevates blood alcohol content to 0.08 g/dL within 2 hours.
Alcohol has many negative psychological and pathophysiological consequences in
adolescents. Teenagers who start consuming alcohol before age of 15 are 4 times more
likely to be alcohol-dependent later in their life [15, 16]. Heavy alcohol consumption
increases risks of early death such as car crashes and suicides [17]. For
pathophysiological changes, alcohol can permeate to virtually all tissues in the body,
which can lead to significant alterations in organ function [18]. Adolescent alcohol misuse
is associated with increased neurobiological changes, and an increased risk of
developing alcohol usage disorder (AUD) later in adulthood [19]. Brain development,
especially the hypothalamus, has shown to be particularly vulnerable to binge alcohol
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exposure in adolescence [1, 20]. However, the effects on the heart from adolescent binge
alcohol consumption are poorly understood.
Normal Cardiac Growth during Adolescence
Adolescence is a period of rapid growth for both the body and the heart. The heart
grows concurrently along with the increase in body weight [21]. Cardiomyocytes, the heart
muscle cells, are the contracting cells and contain basic contractile units called
sarcomeres, which are arranged in both series and parallel with each other.
Cardiomyocytes become terminally differentiated shortly after birth and mostly lose the
ability to proliferate, although a very low level of cardiomyocytes may maintain
proliferative ability [22, 23]. In order to maintain metabolic demands, heart growth during
childhood and adolescence is by a process called physiological hypertrophy [23].
Hypertrophy itself is defined as increased ventricular volume with coordinated growth in
wall thickness, where individual cardiomyocytes increase size in both length (eccentric)
and width (concentric) [23]. During physiological hypertrophy in childhood and
adolescence, cardiomyocytes become bi-nucleated or multi-nucleated and the cardiac
function is increased or preserved [23]. Adolescent heart growth is regulated by hormones
such as growth hormone [24], insulin-like growth factor 1 [25], as well as thyroid hormones
[22]. By the end of adolescence (20 years old), postnatal hypertrophy can increase heart
mass by two-fold or greater due to the increase in dimensions of cardiomyocytes [23, 26].
Beta-Adrenergic Signaling Activation in the Healthy Heart
Healthy heart function is constantly regulated by the sympathetic nervous system.
The function of sympathetic signaling is to trigger the body’s “fight or flight response” in
order to increase cardiac performance. Two kinds of catecholamines (CAs):
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Norepinephrine (NE, produced primarily in sympathetic nerve endings and to a lesser
extent in the adrenal medulla), and Epinephrine (Epi, produced in the adrenal medulla),
are released to the circulation to act on the beta-adrenergic receptors in organs and
tissues including the heart [10]. CAs bind to the beta-adrenergic receptors (βARs) on the
cardiomyocyte surface, which then activates stimulatory G proteins (Gs). Gs protein
stimulates the effector adenylate cyclase (AC), which converts adenosine triphosphate
(ATP) to the cyclic adenosine monophosphate (cAMP) [27]. The increased cAMP binds
onto protein kinase A (PKA). PKA can phosphorylate and activate multiple downstream
proteins, including phospholamban (PLB) and cardiac Troponin I (TnI) [28].
Phosphorylation of PLN relieves the inhibition on the Ca2+-dependent cardiac
sarcoplasmic reticulum Ca2+ ATPase function [29]. Phosphorylation of TnI reduces
myofilament sensitivity to Ca2+, and therefore increases relaxation of the myofilament for
the next contraction [10, 27, 28]. Beta-adrenergic pathway activation accelerates heart
rate (HR), increases cardiac relaxation, and increases cardiac contractility (Figure 1) [10].
βARs are G protein-coupled receptors and contain three subtypes: β1-ARs, β2-ARs, and
β3-ARs. In healthy human hearts, β1-ARs are the dominant ARs that are expressed in
cardiomyocytes [30].
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Figure 1. Schematic of Beta-Adrenergic Activation Pathway. Adapted from Berne and Levy Physiology
Chapter 13 (2008). Sympathetic stimulation of the heart results in an increase in cytosolic cAMP and hence
phosphorylation of several proteins by protein kinase A (PKA). An A kinase adapter protein (AKAP) adjacent
to the L-type Ca++ channel facilitates phosphorylation of this channel and possibly nearby SR Ca++
channels (RyR). Other proteins phosphorylated by PKA include phospholamban (PLB) and troponin I.
Muscarinic agonists (e.g., acetylcholine [ACh]), on the other hand, inhibit this sympathetic cascade by
inhibiting the production of cAMP by adenylate cyclase (AC). β-AR, β-adrenergic receptor. (Redrawn from
Bers DM: Nature 415:198, 2002.)

Healthy Heart Structure and Function
The mammalian heart is composed of 4 chambers: right atrium (RA), right ventricle
(RV), left atrium (LA), and left ventricle (LV). Contraction and ejection of blood from the
left ventricle is called systole, and immediately following is diastole when the left ventricle
relaxes and refills blood from the left atria. Together systole and diastole complete one
cardiac cycle. Blood flows passively from the atria to the ventricles as rapid filling (early
ventricular filling), and further atrial contraction (late atrial filling) ejects the rest of blood
to the ventricles during late ventricular diastole. The ratio of peak early LV filling (E)
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velocity to peak atrial filling (A) velocity is a diagnostic indicator of diastolic function.
Decreased E/A ratio can imply impaired LV relaxation, decreased LV compliance, and
restrictive LV filling [31, 32]. Changes to the stiffness of the myofilament protein titin and
remodeling of extracellular matrix are responsible for decreased E/A ratio in heart failure
patients [33]. In a healthy developing human, the E/A ratio gradually increases up to 20
years old (1.88 ± 0.45, mean ± SD) and then starts to decrease as age increases
(decrease muscle compliance) [31]. E/A is commonly measured by non-invasive Doppler
echocardiography.
Systolic function can be measured with Motion mode echocardiography (m-mode
echo). M-mode echo provides valuable diagnostic information such as the ejection
fraction (EF) and fractional shortening (FS). EF is an important index for evaluating heart
pumping function by measuring the fraction of blood ejected into circulation during each
heart contraction [34]. The American Heart Association defines the EF for a healthy
individual between 50%-70%, and EF<40% is considered cardiomyopathy. Reduced EF
indicates systolic dysfunction that the heart is not able to pump enough oxygenated blood
to the body. FS is another index for assessing LV muscle contractile efficiency by
measuring the fraction of diastole dimensions that is reduced during the systole. Enddiastolic volume is a prognostic index for ventricular dilation and LV remodeling [35].
Pathological Hypertrophy in Adults
Heart growth in adults can happen and normally has negative cardiovascular
impacts. Pathological hypertrophy is normally induced when the heart is under various
types of stress [10]. In order to maintain cardiac function and pump as much blood into
the body, the cardiomyocytes tend to lengthen and cause LV dilation and wall thinning,
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which temporally increase the filling volume during diastole [36]. However, although
pathological hypertrophy initially maintains cardiac function, with activation of the βadrenergic signaling, the key difference between physiological and pathological
hypertrophy is that pathological hypertrophy ultimately leads to cardiomyopathies [36].
Pathological hypertrophy is associated with increased rates of myocyte death, fibrotic
remodeling, and decreased systolic and diastolic function [23].
During heart failure, the heart is not able to pump enough oxygenated blood to
perfuse the tissues. Sympathetic signaling starts to hyperactivate and overproduce CAs
from the adrenal medulla and cardiac sympathetic nerve endings [27]. Short-term
activation can compensate and restore cardiac function, but chronic hyperactivation of
beta-adrenergic signaling causes further decrease in cardiac contractility by downregulation of the β1-ARs and desensitization of β1-ARs to CAs [37, 38]. Chronic betaadrenergic activation also negatively affects LV remodeling, fibrosis, and myocardial
metabolism [27].
Repeated episodes of binge exposure have shown to continuously increase
systolic blood pressure in adult rats through beta-adrenergic signaling activation [39].
However, there are no studies which link binge alcohol consumption and beta-adrenergic
activation in adolescence.
Binge Alcohol Effects on the Heart in Adults
The relationship between alcohol intake and heart function is not completely linear.
Light to moderate drinking (1-2 drinks) has shown cardioprotective effects by reducing
coronary artery disease [40]. However, binge pattern alcohol consumption has always
been shown to lead to deleterious cardiovascular effects in adults. Acute binge alcohol
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exposure (drink excessively on a Saturday night out) can transiently increase blood
pressure during the period of intoxication [41]. Binge drinking at least once per month
over the course of a year in young men (18-45) increased resting systolic blood pressure
(SBP) and total cholesterol level compared to same age non-binge drinkers [42]. High
total cholesterol in the blood can increase the risk of heart disease and stroke.
Binge plus chronic alcohol consumption (>5 years) can lead to alcoholic
cardiomyopathy (ACM) [2]. ACM is a type of dilated cardiomyopathy, which is
characterized by dilated LV (increased LV dimensions during diastole), normal or slightly
increased LV wall thickness, increased LV mass, and (in advanced stages) a reduced LV
ejection fraction to <40% [3, 43].
Titin – Determinant of Diastolic Function
The sarcomere consists of thick (myosin) and thin (actin) filaments for generating
the active force and titin filaments for passive elasticity. The elastic spring like protein titin,
encoded by TTN, connects Z-disk and M-band region of the half sarcomere. The TTN
gene contains 368 exons and multiple splice pathways that give rise to isoforms with
different spring compositions [44]. At the level of the cardiomyocyte, titin is responsible
for diastolic passive tension. The passive tension depends on the expression ratio of
compliant and stiff titin isoforms and the phosphorylation of residues on titin elements
[45]. When the sarcomere length increases, passive tension increases along with the
extension of titin. The two cardiac isoforms expressed in adulthood have been illustrated
in M. LeWinter’s and H. Granzier’s review paper (Figure 2). The relatively small ∼3.0 MDa
isoform is known as N2B titin. The N2B spring portion contains tandem Ig domains, PEVK
segment (rich in proline, glutamate, valine, and lysine residues), and the N2B segment.
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When the sarcomere stretches, tandem Ig segments extend first and then the PEVK
segment, followed by the N2B segment which elongates last [44]. The second isoform
contains an extra N2A element, and is termed N2BA titin. The N2BA isoform has a longer
PEVK segment and a variable number of additional Ig domains resulting in a ∼3.3-3.5
MDa size [44, 46]. The longer N2BA isoform is more compliant than the shorter N2B
isoform [47]. Both isoforms of titin are co-expressed in the cardiac myocyte, and the ratio
determines passive stiffness [48]. In the adult rodent LV, the N2B isoform predominates,
therefore passive stiffness is high [49]. In larger mammals, the N2BA isoform expression
increases. The human LV has a titin isoform expression N2BA/N2B ratio of 0.6 [44, 49],
therefore human hearts are more compliant than those of rodents.
Titin isoform switches have been reported in cardiac diseases. In a study on dilated
heart failure canine model, a decreased N2BA/N2B ratio was found compared to normal
dogs without changes in total titin expression, and therefore the heart had much increased
passive stiffness [50]. However, in human end-stage dilated cardiomyopathy patients, the
average N2BA/N2B ratio was shifted from approximately 30:70 in controls to 42:58, due
to increased expression of N2BA-isoforms to increase the heart compliance [33, 51]. The
opposite findings on titin isoform shift are thought to be possible due to the different stages
of DCM, that the ratio of N2BA/N2B decreases at early stage but eventually the ratio
increases in the late-stage dilated cardiomyopathy [44].
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Figure 2: Schematic of Titin in the Cardiac Sarcomere. Adapted from M. LeWinter and H. Granzier
(2010). N2B: shorter and stiffer titin isoform; N2BA: longer and more compliant titin isoform.

Cardiac Metabolism in the Heart
Cardiomyocytes can utilize different energy substrates such as fatty acids,
carbohydrates (glucoses and lactates), ketones, and amino acids, to produce the
maximum ATP for the high contractile demands. Early in cardiac development, glycolysis
is the major source of energy for proliferating cardiomyocytes, and fatty acid oxidation
becomes the primary metabolic pathway for generating ATP shortly after birth [23, 52].
Fatty acid metabolism provides 40%-60% of the total energy produced in the heart, with
the remainder of the energy provided by glucose metabolism and other substrate
metabolism [53] (Figure 3). During heart failure, cardiac energy production is normally
compromised by impaired ATP production in mitochondria. Less efficient glucose
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metabolism increases in the failing heart [54] and fatty acid metabolism beta-oxidation
decreases [55].

Figure 3. Energy Production and Expenditure in Cardiomyocytes of Healthy and Failing Heart.
Adapted from T. Tuomainen and P. Tavi (2017). Normally, most of the cardiomyocyte ATP is produced
via oxidation of fatty acids and consumed mainly by myosin ATPase in the contractile machinery to
produce the force of heart contraction. In the failing heart, the metabolic phenotype shifts towards the use
of glucose oxidation. At the same time, changes in ion homeostasis reduce the cardiac efficiency, which
together with the impairments in energy production leads to insufficient force production. FATP, fatty acid
transporter; MCT, monocarboxylate transporter; GLUT, glucose transporter; OXPHOS, oxidative
phosphorylation.

Alcohol exposure is associated with changes in fatty acid metabolism gene
expression. In one study, a 6 week old male C57BL/6J mouse model of chronic alcohol
exposure showed increases in fatty acid uptake along with decreases in cardiac function
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[56]. The protocol was for 12 weeks of chronic alcohol feeding in groups with different
concentrations of EtOH (10%, 14%, 18% v/v). The treatment started when the mice were
at an developmental period approximating to human adolescence to full adulthood [57].
Intra-myocardial lipid accumulation was found in all ethanol-fed groups and was
significantly correlated with increased myocardial triglyceride content [3, 56]. Long-chain
fatty acid uptake was evaluated in isolated cardiomyocytes and was increased in a dosedependent manner [3, 56]. This study found Scd-1 gene up-regulation after alcohol
exposure. Scd1 encodes for stearoyl-CoA desaturase 1, and it is an enzyme that
catalyzes the rate-limiting step in mono-saturated fatty acid synthesis. Fatty acid synthase
(fasn) and lipoprotein lipase (lpl), which are essential for de novo fatty acid synthesis,
were not changed by chronic alcohol exposure in these mice [3, 56]

CHAPTER THREE
METHODS
Animals and Tissues
All animal protocols were approved by the Loyola University Chicago Institutional
Animal Care and Use Committee (IACUC). Outbred Wistar male rats were purchased
from Charles River Laboratory (Wilmington, MA) at the age of post-natal date (PND) 25,
and they were exposed to the binge alcohol protocol between the age of PND 37 - 44,
which is equivalent to the early adolescent period in human [58, 59]. When the rats arrived
at PND 25, they were left un-disturbed for 5 days. Rats were randomly pair-housed within
the same treatment group in environmentally controlled conditions. Rats were kept on a
12/12-hour of light/dark cycle with the lights switched on at 7 AM. Rats had free access
to pellet food and water. All measures were taken to minimize pain and suffering.
At the end of the protocol, rats were euthanized by rapid decapitation immediately
after echoes. Hearts were rapidly dissected out and separated by LV free wall, septum,
RV, and atria immediately after euthanasia. Tissues were stored in 1.2 mL cryogenic vials
(430658, Corning), flash frozen in liquid nitrogen, and stored at -80 °C. Four whole LVs
from the each group (LV free wall and Septum together) were preserved differently and
used for H&E staining.
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Adolescent Binge Alcohol Exposure Paradigm
This thesis project utilized a well-established repeated binge alcohol exposure
paradigm as previously described [1, 60] with a few small modifications as described
below (Figure 4). Briefly, to minimize handling stress, each rat was pre-handled from PND
30-36 for 5 minutes at the same time from 9 AM to 10:30 AM for 7 days. On PND 30-31,
we first introduced human interactions by opening the cages and had our hands leaning
against each cage. On PND 32, we further interacted with the rats while they were free
moving in the cage. On PND 33, we picked them up from the tail for the first time. On
PND 34, we started to hold them at the scruff for several seconds in our arms. On PND
35 we introduced the gavage needles by holding the needle tip in their mouth for a few
seconds. Lastly, on PND 36, we performed a dry run gavage by sending the needle down
the throat to their stomach.
On PND 37, cages were randomly assigned and divided into three groups: Water,
Binge, or Acute. All rats received their treatment once per day via oral gavage at the same
time between 9 AM to 10:30 AM. The Binge rats were given food-grade EtOH (Everclear,
190 proof, Luxco) diluted in tap water at a dose of 3g/kg body weight (20%
volume/volume) from days 1-3, water only on days 4 and 5, and back to EtOH on days 68. The Water group had water equivalent (3g/kg) for all 8 days. The Acute group received
water equivalent for first 7 consecutive days, and EtOH for the last dose on PND 44 to
account for the acute effects of alcohol present in the rat’s system vs. the repeated binge
pattern (Figure 4). All rats were weighed on PND 36, 38, 41, and 43 for recalculation of
the gavage dose. Final body mass on PND 44 was also recorded. Water intake of each
cage was measured by weighing the water bottles every other day. Food intake of each
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cage was also monitored by weighing the pellet chow before and after the 8-day
treatment.
Echo
1

7 days

Pre-handle

Binge
(n=21)

Pre-handle

Acute
(n=13)

Pre-handle

2

3

5

4

7

6

8

H2O

EtOH

H2O

Euthanasia

Water
(n=22)

PND 30

Echo

EtOH

H2O
PND 37

EtOH
PND 44

Figure 4. A 7-Day Prehandle Period Plus 8-Day Treatment Paradigm Given to Three Groups of Male
Wistar Rats. All rats were given food-grade EtOH diluted in tap water at a dose of 3g/kg body weight (20%
volume/volume), or water equivalent once per day via oral gavage. The Binge group received first three
days and last three days of EtOH and 2 days of water gavage in between. The Acute group received water
equivalent for 7 consecutive days and the EtOH for the last dose on PND 44 for control of acute alcohol
stress. The Water control group received water equivalent all 8 days. Echocardiogram was performed both
before the 8-day treatment and one hour within the last gavage prior to euthanasia. Baseline echo was
done on PND34 during late pre-handling week, and post treatment echo was performed within the hour
between the last dose of treatment and euthanasia.

M-mode and Doppler Echocardiography
Both motion mode (M-mode) and Doppler echocardiography (Vevo 2100,
VisualSonics) were used to measure cardiac structure and function changes with
adolescent binge alcohol exposure. Baseline echoes were performed on PND 34. Post
treatment echoes were measured within one hour after the last dose of treatment on PND
44 (Figure 4). Rats were under 5% isofluorane for the initial anesthesia and then all the
measurements were performed at 2% isofluorane stable state. All echo measurements
were performed when rats were placed on an animal-handling platform at 37°C. Both
baseline and post treatment echo measurements were performed by CVRI animal
surgeon Quan Cao, MD. The LV short-axis view was used to obtain B-mode two-
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dimensional images and M-mode tracings of LV posterior and anterior wall. Multiple echo
measurements were captured for each rat. Heart rate (HR) was recorded while rats were
under 2% stable isofluorane anesthesia.
LV end-systolic and end-diastolic diameters (LVESD and LVEDD) and posterior
wall thickness at diastole (LVPWd) were measured using M-mode echo. End Diastolic
Volume (LVEDV) was calculated using formula of Teichholz: LVEDV =7.0/(2.4+LVEDD)
* LVEDD3, and end-systolic volume was LVESV =7.0/(2.4+LVESD) * LVESD3. Fractional
shortening (FS), an index for systolic function, was calculated using the equation
FS%=(LVEDD-LVESD/LVEDD) * 100% [34]. Stroke volume (SV) is the difference of
LVEDV and LVESV of each animal, and it is the volume of blood ejected from the LV
during each systolic period. Ejection fraction (EF) is the ratio of the SV to the LVEDV:
EF% = (SV/LVEDV) *100%. Final cardiac output (CO), which is the volume of blood
ejected from the LV to the aorta per minute, was calculated using CO= HR * SV.
Blood Alcohol Content Measurement
Blood alcohol content (BAC) measurement was performed as described previously
[61]. Briefly, trunk blood from each rat was collected in heparinized tubes and centrifuged
at 3,000 rpm for 10 min at 4°C. Plasma was centrifuged out and stored at -20°C. BAC
was measured using Alcohol Reagent Set (A750439, Pointe Scientific, INC.) and read at
340nm absorbance using Infinite 200 PRO (Tecan). Standard curves for extrapolating the
alcohol level of each rat were made based on dilutions using pre-measured alcohol
standards (A7504-STD, Pointe Scientific, INC.).
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H&E Histological Staining
After euthanasia, the LV free wall (n=4 in each group) was dissected out
immediately and incubated in 10% formalin overnight. The tissue samples were
embedded in paraffin and sent for H&E staining to the histology lab at Loyola University
Chicago Medical Center. Individual cardiomyocyte concentric and eccentric hypertrophy
was visualized under a light microscope (400x), and quantified by ImageJ software as
previous described [2]. Image measurements were analyzed by three blinded individuals.
Corticosterone Assay
Plasma levels of corticosterone were measured using commercially available
DetectX Corticosterone Enzyme Immunoassay kit (K014-H1, Arbor Assays) according to
the manufacturer’s instructions. Briefly, 5μL of plasma from each rat and 5μL of
Dissociation reagent was pipetted into 1mL Eppendorf tubes. After vortex and incubation
for 5 minutes, 490μL of diluted Assay buffer was added to achieve 1:100 dilution. Next,
50μL of the total 500μL of diluted sample was added to the 96-well plate provided from
the kit. 50μL of Assay buffer was also added in each sample well. 25μL of Detex
Corticosterone Conjugate as well as the same volume of Corticosternone Antibody were
added separately into each sample well using a multichannel pipet. The plate was
incubated at room temperature for an hour with gentle shaking. Each well was then
aspirated and washed with 300μL Wash buffer 4 times. 100μL of the TMB Substrate was
added into each well with a multichannel pipet and incubated for another 30 minutes
without shaking. Finally, 50μL of the Stop Solution was added with a multichannel pipet.
Each sample was prepared in triplicate. The plate was read at 450nm absorbance using
Infinite 200 PRO (Tecan) reader to determine the optimal density (OD) of each sample.
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Corticosterone level of each rat was calculated from the raw OD using 4 parameter logistic
curve (4PLC) fitting.
BCA Assay
LV tissue samples were used for BCA assay (23225, Pierce TM BCA protein Assay
Kit, Thermo Fisher Scientific) to determine protein concentrations. Briefly, 2.5μL tissue
homogenates from each LV sample was pipetted into a 96-well plate, and 22.5μL ddH2O
was added to achieve a final 10-time dilution. Each sample was prepared in triplicate on
the plate. A ratio of 50:1 solution of Reagent A and Reagent B (provided in the kit) was
prepared as the assay reagent. Then 200μL of the assay reagent was added in each well
with a multichannel pipet. The plate was left on a shaker (300rpm) for 30 seconds and
then transferred to a 37°C incubator for another 30 minutes. Then the plate was read at
562nm on Infinite 200 PRO (Tecan) reader. Standard curves for interpolating rat samples
were made based on a series of dilutions using BSA standards provided in the kit. BCA
assay was later used for equalizing sample loadings in multiple experiments: specific titin
isoform gels, western blots, PKA assay, and LV tissue triglyceride level assay.
Titin Isoform Switch Gel
LV free wall tissue from each animal (30-60 mg) was kept in Standard Relaxing
Buffer (SRB) solution with triton X100. Tissues were homogenized with an electric
homogenizer (GLH 850, Omni International) at 7500 rpms for 3 seconds, repeated twice.
After washing with SRB solution (without triton X100) and centrifuging, the pellet from
each sample was weighed and solubilized in 9M urea at 1:10 (weight/volume). Samples
were the sonicated for 1.5 seconds, 3 times. BCA assay was then performed to obtain
the protein concentration of each sample.
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We made specialized titin isoform gel using a 6% acrylamide plug (distilled water,
40% acrylamide, 0.5M Tris pH 6.8, 10% SDS, 10% APS, and 5 µL TEMED) combining
with 1% agarose resolving gel. 15μg of total protein from each sample was loaded on the
gel and run for 2.5 hours at 15 mA constant current at 4°C. Titin isoforms were visualized
after staining with 0.2% coomassie solution overnight and fixed in de-staining solution
(10% methanol and 7.5% glacial acetic acid). Additional samples were sent to Dr. Charles
Chung’s lab in Wayne State University for titin isoform separations.
Western Blots
Western blot samples were prepared using the same method as the titin gel
preparation. Total tissue lysate (6 μg) were subjected to SDS Page using BoltTM 4-12%
Bis-Tris plus gels (NW04122BOX, Thermo Fisher Scientific) at 180 volts for 30 minutes,
and transferred to nitrocellulose membrane using a wet transfer apparatus for one hour
at 10 volts (1620115, Bio-Rad). The membrane was blocked with blocking buffer (Licor)
in TBS and incubated with primary antibodies overnight at 4°C against cardiac phosphoTroponin I (1:1000, 4004S, Rabbit, Cell signaling) and total cardiac Troponin I (1:10,000,
Mouse, IPOC Inc.). The following morning, secondary antibodies (1:10,000, Licor) were
added and the membrane was then incubated at room temperature for 1 hours.
Secondary antibodies were Goat anti-mouse for red channel (800nm), and Goat antirabbit for green channel (700nm). Membrane was visualized with Azure c600 imager
(AzureBiosystems) and analyzed using Image Studio Lite software.
Plasma Triglyceride and Cholesterol Levels Measurements
Plasma levels of triglyceride and cholesterol were measured using Infinity

TM

Triglycerides Reagents (TR22421, Thermo Fisher Scientific) and Infinity TM Cholesterol
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Reagents (TR13421, Thermo Fisher Scientific), according to manufacturer’s instruction.
Briefly, for triglyceride level, 3μL of plasma from each rat was added with 300μL
Triglycerides Liquid Stable Reagent into a 96-well plate. The plate was incubated for 300
seconds at 37°C and read at 500nm using Infinite 200 PRO (Tecan) reader. For
measuring cholesterol level, 3μL of plasma from each rat was added with 300μL
Cholesterol Liquid Stable Reagent into a 96-well plate. The plate was incubated for 300
seconds at 37°C and read at 500nm using Infinite 200 PRO (Tecan) reader. Both
triglycerides and cholesterol measurements were performed in triplicate. Standard curves
for interpolating rat samples were made based on a series of dilutions using triglyceride
and cholesterol standards (TR22923, and TR13923, Thermo Fisher Scientific),
respectively.
PKA Activity Assay
PKA activity was measured using a commercially available Protein Kinase A
Activity Kit (ADI-EKS-390A, Enzo Life Sciences). LV free wall tissue (30-60 mg) was
homogenized and prepared in the activated cell lysis buffer (provided in the kit). BCA
assay was then performed to determine total protein concentration from each sample.
15μg of total protein was used for the assay. PKA activities of rat tissue samples were
interpolated based on the standard curves.
RNA Extraction and Sequencing
LV free wall tissue (30-60 mg) was used for total RNA extraction. RNA was isolated
using RNeasy plus mini kit (74134, Qiagen) according to the manufacturer’s instructions.
Briefly, frozen tissue was homogenized using a pellet pestle mixer (pellet pestle #12-141361; motor 12-141-364; Fisher Scientific) in Buffer RLT Plus. Homogenates were then
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transferred into gDNA Eliminator spin column with 2mL collection tube and centrifuged
for 30 seconds at 10,000g. 1 volume of 70% EtOH was added to the flow through. 700μL
of sample solution was transferred on to an RNeasy spin column with collection tube, and
centrifuged for 15s at 10,000g. 500μL of RPE buffer was added and centrifuged for
another 2 minutes at 10,000g. 30μL of total RNA was eluted from each sample from the
RNeasy spin column into a new 1.5mL collection tube. Isolated RNA concentration in
each sample was measured using NanoDrop OneC (Thermo Fisher Scientific). Genomic
DNA contamination was not identified by 2% agarose electrophoresis gel. Illumina RNA
sequencing was performed with total RNA (Water n=4; Binge n=4) at University of
Chicago Genomics Facility.
Total cDNA Synthesis and qPCR Measurement
Total RNA (1 μg) was reverse transcribed using iScript

TM

Advanced cDNA

synthesis kit (1725038, Bio-Rad). The resulting cDNA was diluted to 5ng/μL using
nuclease-free water. Quantitative real time PCR was performed in triplicate using
PowerUp SYBR Green Master mix (A25776, Thermo Fisher Scientific) with primers to
specific genes (Table 1). Eno3, Rai1, Acadl, Lpl, Sln, Eln, and Actb primers were
commercially available from the realtimeprimers.com. The primer sets FasN and Nppa
have been previously published [62, 63]. No-template controls were performed to ensure
that there was no reagent or primer contamination. The transcript fold changes for every
gene expression were calculated using ΔΔCt method and compared to the housekeeping
gene beta actin (atcb) values.
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Table 1. List of Primers for Gene Expression Changes by Binge Alcohol Exposure. Primers used for
qRT-PCR reactions for determining LV tissue key fatty acid metabolic gene expressions, and other
important gene down regulations from RNA seq data (rat).

Statistics
All data were analyzed using Microsoft Excel and Prism 8.0.2 (Prism, CA). H&E
data were measured using ImageJ. Food intake and the comparison of the H&E data
were analyzed using two-tailed unpaired t-test, and a p-value of less than 0.05 was
considered as significant. Comparisons between all Water, Binge, and Acute groups
(BAC, corticosterone level) were analyzed using one-way ANOVA, followed by Tukey’s
post hoc test. Body mass measurements were analyzed using two way repeated measure

25
ANOVA with Tukey’s multiple comparisons post hoc test. Water intake and the echo data
(LVEDD, LVEDV, LVESD, LVESV, LVPWd, EF, FS, SV, CO and the E/A ratio) were
analyzed using two way repeated measure ANOVA with Sidak’s multiple comparisons
post hoc test. The heart weight/ body weight ratio, passive tension, titin isoform
comparisons, PKA activity, the pTnI/total TnI ratio, qPCR data, and the lipid prolife
(plasma cholesterol, plasma triglyceride, tissue triglyceride level) between the Water and
the Binge group were analyzed by two-tailed unpaired t-test. All values are presented as
mean ± SEM.

CHAPTER FOUR
RESULTS
Adolescent Binge Alcohol Exposure Paradigm Establishment
In order to study the effects of binge alcohol consumption on the heart during
adolescence, we utilized a well-established adolescent rat model of repeated binge
pattern alcohol exposure with modifications. Seven days of initial handling period was to
reduce the stress by human handling and gavage tools. The binge pattern alcohol
exposure protocol was performed at the age of PND37 to PND 44. Plasma blood alcohol
content (BAC) was measured from the collected truck blood one hour within the last
gavage. Both the Binge group and the Acute group reached expected BAC of average
0.08 g/dL, and Water control rats had BAC of 0 g/dL (Water n=16, Binge n=15, Acute
n=8; p<0.0001 Water vs. Binge, and Water vs. Acute; p<0.0001, by one way ANOVA with
Tukey’s multiple comparisons post hoc test; Figure 5A). The Binge and the Acute rats
had similar BAC (p=0.1149). The adrenal gland secretes glucocorticoid hormones as an
essential physiological response to alcohol stress. Glucocorticoid hormones, cortisol in
humans and corticosterone in rats and mice, regulate many processes in the body
including the mobilization of energy stores and immune function [64, 65]. Plasma
corticosterone concentration was also measured in all three groups to determine the
stress levels. The Acute group had a significant increase in corticosterone level,
suggesting the very first binge dose of alcohol caused acute stress to the rats (p=0.0144
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Water vs. Acute; p=0.1191 Water vs. Binge; p=0.5718 Binge vs. Acute; p=0.0169, by one
way ANOVA with Tukey’s multiple comparisons post hoc test, Figure 5B). The Binge rats
had gradually reduced the stress level with the repeated alcohol exposure. The Water
and the Binge groups had similar overall food intake after the 8-day treatment (Water n=4
pairs, Binge n=4 pairs; p=0.1598 by unpaired t-test; Figure 5C). The Binge rats also had
similar water intake compared with the Water control rats during the treatment (Water n=4
pairs, Binge n=4 pairs; pinteraction=0.0066, psource
variation-Time=0.2092

of variation-Alcohol treatment=0.4329,

psource

of

by two way repeated measure ANOVA with Sidak’s multiple

comparisons post hoc test; Figure 5D). Water and food intake of the Acute group was not
measured since the rats only received alcohol at the last gavage. All three groups had
similar body mass increase during the treatment (average body mass on PND38 to
PND44: Water n=21, 156.5 ± 4.0 g to 225.7 ± 5.6 g SEM; Binge n=22, 161.9 ± 2.9g to
230.0 ± 4.0 g SEM; Acute n=13, 152.5 ± 4.1 g to 222 ± 5.5 g SEM; pinteraction=0.9325,
psource

of variation-Alcohol treatment=0.4683,

psource

of variation-Time<0.0001

by two way repeated

measure ANOVA with Tukey’s multiple comparisons post hoc test; Figure 5E).

28
Water

B

ns

****
0.15
0.10
0.05
0.00

ns

4000

2000

100

0

E
pinteration= 0.0066

Body Mass (g)

60

40

20

ns

200

0

D
Water Intake (mL/animal)

C

*

6000

Corticosterone (pg/mL)

Blood Alcohol Content (g/dL)

****
0.20

Acute

Food Intake (g/animal)

A

Binge

250

pinteraction= 0.9325

200
150
100
50

0
36

38

40

42

Post-Natal Day

44

46

0
32

34

36

38

40

42

44

Post-Natal Day

Figure 5. All Three Groups had Expected BAC and Corticosterone Levels, and all Groups had
Similar Food and Water Intake and Body Growth. Three groups: Water (empty circle, solid line), Binge
(empty square, dash line), and Acute (empty triangle, dotted line). (A) Binge and Acute groups reached
blood alcohol content (BAC) of expected 0.08 g/dL. Water group had 0 g/dL BAC level (****p<0.0001 Water
vs. Binge, ****p<0.0001 Water vs. Acute; p=0.1003 Binge vs. Acute; Water n=16, Binge n=15, Acute n=8;
p<0.0001 by ordinary one way ANOVA with Tukey’s multiple comparisons post hoc test). (B) Acute group
had increased plasma corticosterone level than the Water group (*p<0.5 Water vs. Acute; Water n=8, Binge
n=8, Acute n=8; p=0.0169 by ordinary one way ANOVA with Tukey’s multiple comparisons post hoc test).
(C) Both Water and Binge groups had similar amount of food intake (Water n=4 pairs, Binge n=4 pairs,
p=0.16 by unpaired t-test). (D) Both Water and Binge groups had similar amount of water intake (Water
n=4 pairs, Binge n=4 pairs; pinteraction=0.0066, by two way repeated measure ANOVA with Sidak’s multiple
comparisons post hoc test). (E) All three groups had similar rate of growth during the 8-day treatment
(pinteraction=0.9325, Water n=20, Binge n=21, Acute n=13; by two way repeated measure ANOVA with
Tukey’s multiple comparisons post hoc test).

Cardiac Structural and Functional Changes by Binge Alcohol Exposure
We hypothesized that binge pattern alcohol exposure in adolescence would
decrease cardiac function and increase pathologic hypertrophy, as previously shown in
adult alcoholic cardiomyopathy patients [3]. To assess the effects on heart functional and
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structural changes during adolescence, I retrieved the raw echo measurements data (M
mode and Doppler) by our facility animal surgeon Dr. Quan Cao from baseline (prehandle
period) and at post treatment (within one hour after the last dose). Firstly, no differences
in echo parameters were found between the Water and Binge groups at baseline in all
parameters (Figure 6). While both groups had increased LV end-diastolic diameters
(LVEDDs) after 8-day treatment as they age, the Water group had larger LVEDDs
compared to the Binge group at post treatment (baseline vs. post: p<0.0001 Water,
p<0.0001 Binge; at post treatment: p=0.0072 Water vs. Binge; pinteraction=0.0015, by two
way repeated measure ANOVA with Sidak’s multiple comparisons post hoc test; Figure
6A, B). By calculation using the Vevo 2100 analytical software, both groups increased LV
end-diastolic volumes (LVEDVs) with time (baseline vs. post: p<0.0001 Water, p<0.0001
Binge), but the Binge group had smaller LVEDV compared to the Water group at post
treatment (p=0.003 at post treatment, 240±8.41μL vs. 205.3±6.40μL, Water vs. Binge;
pinteraction=0.0008 significant by two way repeated measure ANOVA with Sidak’s multiple
comparisons post hoc test; Figure 6C). Smaller end diastolic dimensions post treatment
suggest the possibility of slower heart growth from adolescent binge alcohol exposure.
The Water group increased LV end-systolic diameters (LVESDs) after the 8-day
treatment, whereas the Binge group kept similar LVESDs (baseline vs. post: n=14,
p=0.0015 Water; n=14, p=0.2852 Binge). The Water group had bigger LVESD compared
to the Binge group at post treatment (p=0.007 Water vs. Binge; pinteraction =0.0048
significant by two way repeated measure ANOVA with Sidak’s multiple comparisons post
hoc test; Figure 6A, D). Based on calculation with the measured systolic diameters, Water
rats had an increase in LV end-systolic volumes (LVESVs) with time (p=0.0145, n=14),
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and at post treatment Water group had larger LVESVs than the Binge group (p=0.0278,
pinteraction=0.0073 by repeated measure two way ANOVA with Sidak’s multiple
comparisons post hoc test; Figure 6E).
Ejection fraction (EF) is commonly assessed as a clinical index for evaluating the
contractile function of the heart. We analyzed the EF for both groups of rats. Here, EF
was calculated using the equation EF = [(EDV-ESV)/EDV)]*100%. The Water group
remained similar EF at both echo time points (Water baseline vs. post: 79.8 ± 1.5 % vs.
81.6 ± 1.7 %, p=0.4773, n=14), but opposite as we hypothesized, the EF of the Binge
group significantly increase post treatment (Binge baseline vs. post: 79.0 ± 1.3% vs. 85.9
± 1.5%, p=0.0005, n=14; pinteraction=0.0342 by two way repeated measure ANOVA with
Sidak’s multiple comparisons post hoc test; Figure 6F). Next, we analyzed the fractional
shortening (FS) of the two groups. FS is the fraction of a diastolic dimension that is
reduced in systole, and is a similar measurement to EF. The Binge group had an increase
in FS post treatment (Binge baseline vs. post: 48.7 ± 1.4% vs. 57.5 ± 1.7%, p=0.0001;
n=14 Water, n=14 Binge; pinteraction=0.0173 by two way repeated measure ANOVA with
Sidak’s multiple comparisons post hoc test; Figure 6G). In addition, both groups increased
LV posterior wall diameter during diastole (LVPWd, baseline to post: Water 1.55 ± 0.04
mm to 1.71 ± 0.05 mm, p=0.018, n=15; Binge 1.64 ± 0.05 to 1.88 ± 0.07 mm, p=0.0005,
n=15). The Binge group had larger LVPWd comparing to the Water group post treatment,
indicating thickening of the LV chamber with binge alcohol exposure (p=0.0285 Water vs.
Binge; pinteraction=0.3272, psource of variantion-Time <0.0001, psource of variation-Alcohol treatment =0.0242
by two way repeated measure ANOVA with Sidak’s multiple comparisons post hoc test;
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Figure 6H). Higher EF and FS indicates increased systolic function in the Binge group
after binge alcohol exposure compared to the Water group.
The increase in systolic and diastolic parameters in the Water group represents
the normal growth of the heart over 8 days in adolescent rats. M-mode echo data showed
smaller diastolic dimensions but increased heart contractility in the Binge group post
treatment. Next we wanted to compare overall cardiac output (CO) of two groups, first we
had to calculate stroke volume (SV) for the two groups. Using the equation of SV = EDV
– ESV, both the Water group and the Binge group increased SV post treatment (baseline
to post: 128.7 ± 5.7 μL to 196.8 ± 7.0 μL, n=15, Water; 126.0 ± 3.6 μL to 176.2 ± 6.0 μL,
n=14, Binge; p<0.0001 for Water and Binge, respectively). The Water group had bigger
SV than the Binge group at post treatment (p=0.0319; pinteraction=0.0069 by two way
repeated measure ANOVA with Sidak’s multiple comparisons post hoc test; Figure 6I).
Heart rate (HR) was measured when rats were under stable 2% isoflurane during each
echo procedure. Using the equation CO = HR * SV, two groups maintained similar
increase in CO after the treatment (baseline vs. post: Water 56.5 ± 3.0 mL/min vs. 81.1 ±
3.6 mL/min, n=13; Binge 56.9 ± 1.8 mL/min vs. 81.9 ± 4.4 mL/min, n=13; p<0.0001 for
Water and Binge, respectively; psource of variation-Time<0.0001 analyzed by two way repeated
measure ANOVA with Sidak’s multiple comparisons post hoc test; Figure 6J).
M-mode echo data showed binge alcohol increased systolic function in
adolescents, as the opposite results of what we originally anticipated from the adult
patients. Sympathetic activation is known to be stimulated in adult alcoholic
cardiomyopathy patients, and it can temporarily restore heart function [3]. Adolescent rats
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had smaller diastolic dimensions but still were able to maintain the same CO as the Water
controls post binge alcohol exposure. We then hypothesized that the 8-day binge alcohol
exposure in adolescence induced compensatory mechanism by sympathetic activation to
maintain cardiac output (CO) by increasing systolic function.
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Figure 6. Motion Mode Echocardiograph Parameter Changes. Water (bold circle, straight line) and
Binge (empty square, dashed line) (A) Representative M-Mode echocardiograph images of Water and
Binge group at both baseline and post treatment measurements. Distance between dotted lines represent
LVESD; distance between flat lines represent LVEDD. (B, C) Both groups had increased LV end diastolic
diameters and volume post treatment than baseline. At post treatment, Binge group had less of diastolic
diameters (B) and volume (C) comparing to water controls, indicating altered ventricular structure after
binge exposure. (D) Water group had significant increase in LV end-systolic diameters post treatment
than baseline, while Binge group remained similar LVESD. LVESD of Water rats at post treatment is
bigger than binge rats. (E) Water group has a trend towards bigger end systolic volume at post treatment
than Binge, indicating binge alcohol exposure leads to stronger systolic contraction. (F) Binge group had
increased ejection fraction than Water group after binge alcohol treatment. (G) Binge group had
increased fractional shortening than Water group after binge alcohol treatment. (H) Water group had
similar LV posterior wall dimensions at both time points, but binge group had significant increase in
LVPWd at post treatment. (I) Both groups had increased stroke volume at post treatment than baseline.
(J) Water and Binge groups maintained similar cardiac output. *p<0.05 vs. baseline, **p<0.01 vs.
baseline, ***p <0.001 vs. baseline, ****p<0.0001 vs. baseline, #p<0.05 vs. water at post treatment,
#p<0.01 vs. water at post treatment, pinteraction in different parameters by two way repeated measure
ANOVA with Sidak’s multiple comparisons post hoc test.

Because the Acute group had no difference found in post treatment echoes
comparing to Water group (Figure 7), only Water and Binge rats echo data are compared
in the results section.
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Figure 7. M-Mode Echo Data Comparisons between the Water and the Acute Groups. (A, B) The
Water (bolded circle, straight line) and Acute rats (empty triangle, dotted line) had steady increase in
diastolic diameters (A) and volumes (B) post treatment comparing their own baseline, indicating heart
growth during adolescence. Both groups had similar diastolic diameters (A) and volumes (B) between
groups at both time point measurements. (C, D) The Water and Acute rats had similar systolic diameters
(C) and volumes (D) post treatment comparing to their own baseline respectively, and between groups at
both time point measurements. (E) Both the Water and the Acute rats had stable normal EF at two time
points. (F) Both the Water and the Acute rats had stable normal FS at two time points. (G) Both the Water
and the Acute group had similar posterior wall thickness. (H) Both the Water and the Acute group had
increase SV post treatment comparing their own baseline. No difference in SV found between groups
post treatment. (I) Both groups increased CO with time. Both groups had similar CO at post treatment
echo. Water n=8, Acute n=8; *p<0.05, **p<0.01, ***p<0.001, and ****p<0.0001 by two way repeated
measure ANOVA with Sidak’s multiple comparisons post hoc test.
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We measured the heart weight post treatment using an analytical balance (XS64,
Mettler Toledo) in another binge alcohol exposure cohort, which was kindly provided from
Dr. Toni Pak’s lab. Heart weight to body weight ratio of each group was similar between
the Water rats and the Binge rats (Water n=5, Binge n=6; p=0.2231 by unpaired t-test;
Figure 8).
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Figure 8. Heart Weight Comparisons between the Water and the Binge Groups Post Treatment. (A)
Representative heart images of the Water and the Binge rats at PND44 immediately after euthanasia. (B)
Quantitative analysis of the ratio of heart weight to body weight in two groups (Water n=5, Binge n=6;
p=0.2231 by unpaired t-test).

Binge Alcohol Exposure Altered Normal Cardiomyocyte Remodeling
Because of the changes we observed from the M-mode echo, we then investigated
the individual cardiomyocyte morphology using H&E staining. We hypothesized that binge
pattern alcohol consumption increases cardiomyocyte hypertrophy in adolescence. We
assumed all rats had similar cardiomyocyte morphology at baseline conditions. In order
to study the effects after binge alcohol exposure, we compared the cardiomyocytes at
post treatment between two groups. Rat LVs were preserved for H&E staining in 10%
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formalin immediately after euthanasia at PND44 (Water n=4, Binge n=4). Cardiomyocytes
images were captured at base, middle, and apex of the LV using a light microscope (x100
and x400). Multiple representative cardiomyocytes were measured for concentric
hypertrophy and eccentric hypertrophy analysis. Measurements were analyzed and
compared by 3 blinded individuals separately. After the 8-day treatment, Binge group had
increased average cardiomyocyte cross-section area at the middle and the base of LV
compared to the Water group (Apex: p=0.97, 305.9 ± 11.0µm2 vs. 305.4 ± 11.0 µm2,
n#cells=50 vs. n#cells =68, Water vs. Binge; Middle: p=0.0316, 276.8 ± 5.6 µm2 vs. 295.2 ±
5.6 µm2, n#cells=282 vs. n#cells=239, Water vs. Binge; Base: p=0.012, 293.7 ± 6.9 µm2 vs.
320.1 ± 8.0 µm2, n#cells=184 vs. n#cells=182, Water vs. Binge; by unpaired t-test; Figure 9A,
C). Then we measured the longitudinal lengths of the cardiomyocytes (Figure 9B; white
arrows point at intercalated disks, and the length of one cell is measured between two
intercalated disks). The Binge group had longer cardiomyocyte lengths than the Water
group at the Apex (Apex: p=0.0002, n#cells=62 vs. n#cells=41; 69.2 ± 1.9 µm SEM vs. 81.5
± 2.7 µm SEM, Water vs. Binge; Middle: p=0.42, n#cells=81 vs. n#cells= 46, 71.6 ± 2.1 µm
SEM vs. 74.3 ± 2.3 µm SEM, Water vs. Binge; Base: p=0.53, n#cells=58 vs. n#cells=61, 82.1
± 2.6 µm vs. 79.9 ± 2.3 µm, Water vs. Binge; by unpaired t-test; Figure 9D). Adolescent
binge alcohol exposure increased cardiomyocyte eccentric hypertrophy at the apex and
increased concentric hypertrophy at the middle and base positions in the LV. The
difference of hypertrophic increases at different LV positions suggests binge pattern
alcohol altered cardiac structure after only 8 days.
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Figure 9. Binge Alcohol Exposure Alters Cardiomyocyte Concentric and Eccentric Hypertrophy.
(A) Representative H&E histological images of LV cardiomyocyte cross-section areas at locations Base,
Middle, and Apex. (B) Binge rats had increased concentric hypertrophy at the middle and base of LV after
binge alcohol exposure than Water rats. Two groups had similar cross section areas at Apex. (C)
Representative H&E histological images of LV cardiomyocyte Longitudinal section areas at locations
Base, Middle, and Apex. White arrows point at intercalated disks. Each pair of arrows represents
measurement of each individual cardiomyocyte length between intercalated disks. (D) Binge group had
increased eccentric hypertrophy at Apex of LV than Water group (*p<0.05, ***p<0.001 by unpaired t-test).

Diastolic Consequences after Binge Alcohol Exposure Decreased in Adolescence
Doppler echocardiograph (Doppler) was measured at the same time as the Mmode for baseline and post-treatment comparison. Doppler measures E to A ratio (the
ratio of peak velocity from early ventricular filling to peak velocity from atrial contraction
during diastole), which is a marker assessing diastolic function. The Water group
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increased E/A ratio with time, as their hearts are getting more compliant during normal
adolescent growth (p=0.014, n=16, 2.02 vs. 2.5, SE of diff. = 0.20, baseline vs. post). The
binge group maintained the similar baseline compliance post treatment (p=0.717, n=16,
1.98 vs. 2.11, SE of diff. = 0.21, baseline vs. post; by two way repeated measure ANOVA
with Sidak’s multiple comparisons post hoc test; Figure 10A). Binge group still had an E/A
ratio value within a healthy range (E/A >2 for young adults, based on ASE/EACVI
guidelines and standards [32]), but we were very interested to understand the reason for
the smaller E/A ratio in the Binge rats compared to the Water controls at post treatment.
We then studied the possible changes that could lead to the difference in diastolic
function. Diastolic dysfunction is linked to a decrease in LV compliance. Compliance is
determined by both cardiomyocyte passive tension and extracellular matrix protein
compositions. In alcoholic cardiomyopathy patients, both increase in passive tension and
fibrosis by ECM remodeling have been studied to cause decrease in diastolic E/A ratios
[66, 67]. We first hypothesized that adolescent binge alcohol exposure reduces heart
diastolic compliance by increasing cardiomyocyte passive tension. Myofilament passive
tension was measured by our previous lab member Dr. Maxime Heroux, and she found
that the Binge group cardiomyocytes had significantly higher passive tension compared
to the Water group at every sarcomere length (1.8-2.4 µm). Binge alcohol exposure
increased cardiomyocyte passive stiffness after only 8-days of treatment in adolescent
rats. Increased passive stiffness is a common characteristic of diastolic dysfunction,
which can eventually cause heart failure. A stiff LV myocardium can fill with less blood,
thus it also agrees with the M-mode echo data showing the smaller LVEDV in the Binge
group compared to the Water group at post treatment.
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Titin is a spring-like protein that connects the sarcomere Z line to M line and is
responsible for muscle elasticity. The switch in expression levels between isoforms N2BA
(longer and more compliant titin) and N2B (the shorter and stiffer titin) was found in
patients with diastolic dysfunction [51]. Titin modifications can also be responsible for
cardiomyocyte passive stiffness [68]. In order to test whether the increased passive
stiffness was due to titin isoform switching in Binge group, we modified a specialized titin
gel to separate the two isoforms by size (Figure 10D). We then sent more myofilament
samples to our collaborator Dr. Charles Chung’s lab in Wyane State University for titin
isoform visualization. However, after analyzing the results we received from Wyane State,
the Binge group did not show any differences in titin isoforms (Figure 10E), degradation
(Figure 10F), or overall protein expression (Figure 10G). One possibility is that 8-day of
binge alcohol exposure is not long enough for the large titin protein turnover, which has
half-life of 3.5 days [69].
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Figure 10. Binge Alcohol Effects on Diastolic Function. (A) E/A ratio showing a trend towards
decreased diastolic function in Binge group. (B) Specialized titin gel showing two titin isoforms in both
Water and Binge groups. (C) No difference found between the ratio of N2BA over N2B in two groups. (D)
No difference found between the ratio of proteolytic cleavage products (T2) over total titin (TTN) in two
groups. (E) No difference is found between the ratio of TTN over myosin heavy chain (MHC) control in
Water and Binge groups.

We also measured the E/A ratio of the Acute group, and the Acute group had
similar E/A ratio increase as the Water group. (Water n=8, Acute n=8; psource of viariation-Alcohol
treatment=0.703;

p=0.025 Acute baseline vs. post; psource of viariation-time= 0.0057 by two way

repeated measure ANOVA with Sidak’s multiple comparisons post hoc test; Figure11).
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Figure 11. Doppler Echo Results Comparison between Water and Acute Rats. Acute group (empty
triangle, dotted line) showed increase in E/A ratio with time. Water (bold circle, straight line) n=8, Acute
n=8; *p<0.05 Acute baseline vs. post; Water baseline vs. post; by two way repeated measure ANOVA
with Sidak’s multiple comparisons post hoc test.

The Binge Group Increased Beta-Adrenergic Signaling Protein Phosphorylation
We were interested in determining the possible signaling mechanism that led to
increased systolic function in the Binge rats. Beta-adrenergic signaling constantly
regulates systolic function. Activation of beta-adrenergic signaling increases systolic
contraction and HR, and maintains CO under stress conditions [10]. We hypothesized
that binge alcohol exposure increased beta-adrenergic stimulation in adolescent rats.
Firstly, we measured the key beta-adrenergic downstream kinase PKA activity using a
commercially available kit. However, The PKA activity assay did not detect the difference
between the Water and Binge rats (Water n=6, Binge n=7; p=0.6467 by unpaired t-test;
Figure 12A). Although there was a trend towards a 15-20% increase, we think that the
assay was not sensitive enough to detect such a modest increase. Therefore, we
measured beta-adrenergic pathway protein cardiac Troponin I (TnI) phosphorylation
(Figure 12B). TnI, as an inhibitory unit of the troponin complex, inhibits actin and myosin
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interaction during diastole [70]. TnI at S22/23 (S23/24 if the initiating methionine is
counted) is commonly phosphorylated by PKA. TnI phosphorylation decreases
myofilament Ca2+ sensitivity and accelerates heart relaxation [70]. The Binge group had
a 22% increase in TnI phosphorylation at the S22/23 sites compared to the Water group
(ratio of green channel pTnI at S22/23 site to red channel total TnI; Water n=9, Binge
n=15; p=0.0472 by unpaired t-test; Figure 12C).
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Figure 12. Binge Alcohol Exposure Increased Β-Adrenergic Signaling Pathway Protein
Phosphorylation. (A) Water and Binge group had variable PKA activity within the groups, although there
might be a trend towards 15-20 % increase in the Binge group (Water n=6, Binge n=7; p=0.6467 by
unpaired t-test). (B) Western blot image of phosphorylated cardiac TnI at S22/23 and total cTnI. (C)
Binge alcohol exposure increased cTnI phosphorylation. Water n=9, Binge n=15; *p<0.05 by unpaired ttest.

Binge Alcohol Exposure Interrupted Regulatory Gene Expressions in the Heart
The effects of binge alcohol consumption on the adolescent heart are almost
entirely unknown, so we next examined genome wide mRNA expression changes in the
two groups (Water n=4, Binge n=4). Total mRNA was extracted and prepared for RNA
seq from LV myocardium, and we analyzed the genes with significant fold changes after
binge alcohol exposure (Table 1, Figure 13A). Interestingly, mRNA showed down
regulation of several genes for fatty acid metabolism in the Binge group, such as fatty
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acid synthase (fasn), Enolase 3 (eno3), lipid lipase (lpl), and Acetyl-CoA dehydrogenase
(acadl) (Table 3). We performed quantitative real time PCR with primer sets specific to
those genes, respectively (Table 2). Binge group qPCR results did not show significant
expression changes in those genes compared to the Water group (Water n=6, Binge n=6;
Figure 13B). However, repetitive experiments on more animals need to be done for the
qPCR analysis. RNA seq suggested other important gene down regulations such as
sarcolipin (Sln), retinoic acid induced 1 (Rai1), and natriuretic peptide A (Nppa). Sarcolipin
is a small trans-membrane protein that regulates sarcoplasmic reticulum calcium ATPase,
and ablation of sarcolipin increases calcium transport and atrial contractility [71]. Rai1 is
one of the regulatory genes that is responsible for circadian rhythm and brain
development [72]. Natriuretic peptide A production is stimulated with increased systolic
blood pressure to decrease blood pressure. The qPCR results supported the trend of
decreased fold change in nppa and sln (Figure 13C). Both groups had similar
concentrations of triglyceride and cholesterol, indicating normal liver functions (Figure
13D, E). Because the RNA seq data indicated changes in some metabolic gene
expressions with binge alcohol exposure, we further examined the LV muscle tissue
triglyceride level. No difference was found in tissue triglyceride level between both groups
(Figure 13F).
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Table 2. RNA Seq Data. Expression changes in several key myocardial metabolism genes and
myofilament structural genes.
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Figure 13. Binge Alcohol Exposure Changed Various Gene Expressions but not yet to Lipid Profile.
(A) Volcano plot analysis of RNA seq data on changes in gene expressions by binge alcohol exposure.
Expressions of some representative genes for cardiac fatty acid metabolism and sarcomere structures are
labeled. (B) A few key regulatory genes in fatty acid metabolism that had shown down-regulation from RNA
seq, so confirmatory quantitative rtPCR experiments were performed. (C) Genes that are important for
cardiac structures and function (sarcolipin and natriuretic peptide A) were also measured mRNA expression
using qPCR to confirm the RNA seq data. Retinoic acid induced 1 is a gene that had found to be regulating
circadian rhythms and brain development. However, Rai 1 did not show down regulation as expected from
the RNA seq data (Water n=6; Binge n=7). (D, E) Plasma cholesterol and triglyceride level were similar
between Water (n=13) and Binge group (n=14). (F) Both groups also had LV tissue triglyceride level (Water
n=8; Binge n=8).

CHAPTER FIVE
DISCUSSION
Our current understanding of how binge alcohol consumption affects the heart in
adolescence is limited. It is important to determine the consequences of how binge
pattern alcohol exposure would impact the growing heart. The goal of this thesis project
was originally to determine whether binge alcohol exposure affects the structure and
function of the adolescent heart the same way as it does in adults. However, this project
is the first to show that binge alcohol exposure increased systolic function in adolescence
and might slow heart growth. We think the increased systolic function was due to betaadrenergic activation, which was then supported by our TnI phosphorylation data. In
addition, our data also revealed novel findings that short-term binge alcohol exposure in
adolescent rats 1) led to mild diastolic function changes, including smaller E/A ratio and
increased passive stiffness, compared with Water controls; 2) altered cardiomocyte
morphology (increased concentric hypertrophy at the base and middle of the LV, and
increased eccentric hypertrophy at LV apex compared to Water group); and 3) initiation
of a possible energy substrate utilization switch from myocardial fatty acid metabolism to
less efficient glucose mechanism. This project uncovered a possible significant cardiac
health risk associated with underage binge drinking.
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Adolescent Binge Alcohol Exposure Rat Model and Cardiovascular Studies
We utilized a well-established male rat model in our studies. Rats have a more
rapid adolescence than human, so PND 37-44 is approximately equivalent to human
early adolescence. We focused on male rats in this project since the same male model
has been studied and used for many brain development studies [1, 60, 61]. Gavaging
only once per day at 9-10 AM is when corticosterone levels are the lowest in rats
(highest in human due to the opposite circadian rhythm) [64,65]. Low corticosterone
level in the morning allows us to minimize the maximum stress that could be caused by
alcohol administration. Since euthanasia was performed within one hour after the last
gavage, there was high level of blood alcohol circulating in the rat’s body. The Acute
group we introduced allowed us to compare the acute binge dose alcohol administration
would impact to the heart, in order to examine effects from episodic binge pattern
alcohol exposure to the growing heart. The binge group had two days of H2O equivalent
gavage, due to two reasons: 1) to be more physiological relevant since adolescents do
not get access to alcohol all the time; 2) to avoid any possible alcohol addiction by the
body.
M-Mode Results on Heart Function Changes of Binge Group Adolescent Rats
Our echo data showed post alcohol treatment the Binge group had smaller systolic
parameters, increased ejection fraction (EF), and increased fractional shortening (FS).
Instead of decreasing systolic function as in adults [73], binge alcohol exposure in
adolescence increased systolic function in our study. One possible reason may be due to
the activation by beta-adrenergic signaling, and we did identify an increase in
phosphorylation of TnI, an important downstream protein of beta-adrenergic signaling
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pathway. Further experiments such as cAMP activity assay can be performed to measure
the downstream effects of beta-adrenergic activation in adolescent rat hearts.
The heart and body grow rapidly and concurrently in adolescence [21]. Our
interesting results showed that binge alcohol exposure in adolescent rats led to a trend
of reduced heart growth. In adult patients, alcohol has been associated with increasing
heart weight by causing pathological hypertrophy [56]. However, in our adolescent animal
model, binge alcohol exposure did not increase heart mass. We hypothesize there is a
much more complicated mechanism that was activated by binge alcohol exposure, which
involves both reducing physiological hypertrophy and increasing pathological hypertrophy
in the Binge rats. Particularly from the echo data, the Binge group only had half of the
diastolic dimension increase compared to the Water group post alcohol treatment, while
both groups had the same increase in body mass throughout the protocol. Since
adolescence is a rapid growth period for both the body and the heart [21], decreasing the
ratio of heart weight to body weight could decrease the ability of heart to pump enough
oxygenated blood to the body. It might also increase the work burden of the relatively
small heart to maintain the body’s metabolic demands. Whether the slowed heart growth
gradually returns to normal, if they no longer receive binge alcohol exposure, will need to
be further investigated.
Young adults with binge pattern drinking habits have higher blood pressure (BP)
than age-matched non-binge drinkers [42], so it would be interesting to see if this is also
true in adolescents. We have not yet measured BP for adolescent rats in this project. The
tail cuff method of pressure recording would be useful to non-invasively measure the
blood pressure. In addition, cardiac output (CO) is calculated by stroke volume (SV) *
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heart rate (HR). Since echo measurements were performed when rats were under stable
2% isoflurane anesthesia, the daily resting HR may differ when rats are conscious [74].
Although alcohol has been previously shown to cause HR to increase in adolescents
shortly after exposure [20], basal HR seems to be maintained after the intoxication in
female rat models [75]. The basal HR changes have not yet been reported on male
adolescent rats, and it is known that sex is a biological variable in biomedical studies [76,
77]. Telemetry would be a useful tool to measure HR in our male animal groups.
Echo data also suggested LV wall thickening in our Binge group rats after alcohol
treatment. Our Water control group had increased LVPWd with time. Wall thickening
indicates cardiac hypertrophy in adolescent rats after binge alcohol exposure. It will be
interesting to examine whether the thickened LV in Binge group would normalize or
gradually worsen if the animals are allowed to mature into adulthood. Since adolescents
are likely to persist in their drinking behavior into adulthood, another experimental group
with a second set of 8-day binge alcohol exposure would be added to determine long
term binge alcohol effects on heart function and structure (Figure 14).
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Figure 14. Potential Future Paradigm to Observe the Effects to the Heart for Longer Term when
Adolescent Binge Alcohol Exposure Rats Are Allowed to Mature into Adulthood. Water Water: Rats
are getting water equivalent throughout the protocol. Water Binge: rats only receive alcohol treatment in
adult period. Binge Water: rats stop receiving alcohol after PND 44 and allow to mature into adulthood.
Binge Binge: Rats receive first 8 days of binge alcohol exposure in adolescence and another 8 days of
binge pattern alcohol exposure in adulthood.

Diastolic Function Alterations after Binge Alcohol Exposure
We were able to identify diastolic dysfunction at the myofilament level by
measuring the individual skinned cardiomyocyte passive stiffness. We investigated the
spring-like structural protein titin isoform changes by binge alcohol exposure in
adolescence and found similar titin isoforms ratio between two groups. Previous research
has shown end-stage failing human hearts with dilated cardiomyopathy had isoform
transitions to the more compliant N2BA isoform [51, 78], although our experimental Binge
group maintained different but normal cardiac function comparing with Water controls.
We think this is because our paradigm was only for a short period of exposure and the
Binge group was far from being end-stage heart failure. While the paradigm might be
relatively short exposure for observing titin isoform switch (t1/2=3.5 days [69]), posttranslational modifications (PTM) on titin protein has been found to play a very important
role in regulating passive stiffness of the myocyte. One study found that adult heart failure
patients tend to have both a titin isoform switch to N2BA and hypophosphorylation on
certain regions of the protein [79]. In addition, another study showed that specific
hyperphosphorylation on titin spring element PEVK S26 contributed to the passive
stiffness in hearts with diastolic dysfunction [80]. Moreover, our TnI phosphorylation data
suggested beta-adrenergic signaling activation by binge alcohol exposure in
adolescence, and beta-adrenergic activation has shown to alter titin phosphorylation
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which decreased passive stiffness [81]. Mass spectrometry would be a useful tool to
measure titin PTM changes in adolescent rats after binge alcohol exposure.
Our Doppler data showed smaller E/A ratio in Binge group comparing to Water
controls at post treatment. Besides changes in myofilament proteins, remodeling of
extracellular matrix (ECM) is another major factor of diastolic stiffness (Figure 11).
Myocardial fibrosis by ECM remodeling, which fibroblasts increase collagen stiffer isoform
I expression and reduce compliant collagen III expression, is shown to significantly
increase passive stiffness and diastolic dysfunction [68, 82]. Alcohol exposure has been
found to up regulate many ECM encoded gene expressions in adult rat models [83]. This
project has not yet studied the ECM composition after binge alcohol exposure in
adolescent rats, so Masson’s Trichome staining can be performed using our paraffin
embedded heart slices to analyze whether binge alcohol exposure increases fibrosis in
the heart.
Binge Alcohol Exposure Effects on Adolescent Cardiac Remodeling
In patients with diastolic heart failure, pathological concentric hypertrophy
(increases mass and relative wall thickness) or remodeling (normal mass but increased
relative wall thickness) can be observed [31]. Our study is unique because all rats
underwent physiological hypertrophy during the protocol (increased LVEDD, LVEDV, and
LV wall thickening). Even though both the Water group and the Binge group had LV wall
thickening, longitudinal comparison at post treatment showed that the Binge group had
significantly larger LVPWd diameters compared to the Water controls. Interestingly, we
also observed only half of diastolic dimensions increase compared to the Water controls
at post treatment, suggesting smaller heart growth.
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Pathologically hypertrophied myocardium usually slows LV relaxation [31]. Slower
LV relaxation means reduced early ventricular filling from the atria due to the increased
LV diastolic pressure, which in turn increases the proportion of blood left in the LA during
atrial contraction. Ultimately pathological hypertrophy leads to a smaller E/A ratio. The
smaller E/A ratio from the Doppler results and the increased passive tension from the
myofilament measurements support the idea that binge alcohol exposure possibly
initiated the pathological hypertrophy in adolescent rats.
This project is the first study to show that binge alcohol exposure in adolescence
induces different changes in cardiomyocyte morphology at different locations within the
LV (both concentric and eccentric cardiomyocyte hypotrophies). Previously, concentric
hypertrophy has been shown in an adult murine model after chronic alcohol consumption
[84], but the study did not specify or divide LV positions (base, middle, or apex). We think
that adolescent cardiomyocytes at the LV apex lengthened, but cardiomyocytes at the LV
middle and base thickened after binge alcohol exposure. However, early adolescent
cardiomyocyte morphology is not well studied, so it is not clear whether binge alcohol
exposure led to pathological remodeling or slowed the normal physiological remodeling
of the LV. A sub control cohort of only the first 7-day prehandling protocol will be included
for the future study, and the cardiomyocytes at PND37 will be analyzed and then
compared with the cardiomyocytes on PND44 post alcohol treatment. There is a
possibility that adolescence binge alcohol exposure increased heart pathological
hypertrophy but slowed down the normal physiological hypertrophy.

54
Binge Alcohol Exposure and Myocardial Fatty Acid Metabolism
Our RNA seq data and qPCR results suggested the initiation of a switch from the
preferred fatty acid metabolism to a less efficient glucose metabolism in the heart after
binge alcohol exposure in adolescent rats. Multiple fatty acid metabolic genes are shown
to be down-regulated, such as lpl and fasn. The gradual switch from fatty acid oxidation
to glucose metabolism is one of the common characteristics of heart failure [53]. It would
be interesting to examine directly the protein expression, so next step would be to perform
mass spectrometry to identify protein levels for those genes in the tissue samples. The
RNA seq data showed other regulatory gene down regulations, such as Rai 1, a
regulatory protein for circadian rhythm. Our data might explain the binge alcohol
consumption induced sleep disorders observed in adolescents [85].
Our data conclude that 8 days of binge alcohol exposure does not yet change LV
tissue triglyceride level in adolescent rats. Triglyceride buildup in the heart has been
reported in chronic alcoholic cardiomyopathy animal models and adult patients [56, 86].
It would be interesting to further study the threshold at which binge alcohol exposure
begins to cause triglyceride buildup in adolescents.
Summary
Binge alcohol consumption is common in adolescence and little to nothing is
known about how it would affect the growing heart. The overall effects of binge alcohol
exposure on the heart have been under appreciated but the cardiovascular risks can be
tremendous to adolescents’ health. This project for the first time uncovered the structural
and functional changes of the heart after binge alcohol exposure during adolescence. Our
data suggests novel findings that binge alcohol exposure negatively impacts normal
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cardiac growth (including alterations in cardiomyocyte morphology) and heart
compliance. The heart had to compensate for the increase in body demands by
increasing systolic function through beta-adrenergic signaling. In addition, this project is
the first to find that binge alcohol exposure in adolescence down-regulated 58 genes and
up-regulated 10 genes in the left ventricle. Future studies are necessary to determine if
the alterations we observed would be maintained throughout adulthood.
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